Search

everythinglearnresearchcommunity

for

Search:↓

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Women with hirsutism have different levels of omentin-1, which may be linked to the condition and its genetic aspects.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Most women with excessive hair growth have a hormonal cause.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Women with acne and hair loss, even if they have regular periods, often have polycystic ovary syndrome.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

PCOS affects fertility and is linked to obesity and menstrual irregularities; lifestyle changes are recommended for treatment.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Most women lack knowledge about androgens and their excess symptoms.

Women with PCOS have more severe liver disease.